Our Research

Real world health solutions from clinical research


Prospective Study

THEIA development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand – In Publication.

THEIA’s Performance Assessed using a cloud platform

Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke.

THEIA used OCTA for diagnosis of AMD

Quantification of optical coherence tomography angiography in age and age-related macular degeneration using vessel density analysis.

THIEA as multi-modal imaging detection of AMD

Multimodal Retinal Image Analysis via Deep Learning for the Diagnosis of Intermediate Dry Age-Related Macular Degeneration: A Feasibility Study.

Retrospective Study

Towards implementation of AI in New Zealand national screening program: Cloud-based, Robust, and Bespoke.

THEIA as a smoking detection tool

Detection of smoking status from retinal images; a Convolutional Neural Network study.

Want to participate in our research?

Ask us about our research

Associate Professor Ehsan Vaghefi, CEO

You're viewing our
Europe site.

For other regions, please click below: